In vivo reprogramming: A new approach for tissue repair in chronic diseases

Journal Title: Chronic Diseases Journal - Year 2017, Vol 5, Issue 2

Abstract

Medical researchers and biologists have long been fascinated by the possibility of changing the identity of cells, a phenomenon known as cellular plasticity. Now, we know that differentiated cells can be experimentally coaxed to become pluripotent (cellular reprogramming). Recent studies have demonstrated that changes in cell identity are not limited to the laboratory, but also the tissue cells in live organisms are subjected to this process, too (endogenous cellular reprograming). Nowadays “reprogramming technology” has created new opportunities in understanding human chronic diseases, drug discovery, and regenerative medicine. This technology have enabled the generation of various specific cell types including cardiomyocytes, pancreatic beta cell, and neurons, from patient’s cells such as skin fibroblasts. Reprogramming technology provides a novel cell source for autologous cell transplantation. But, cell transplantation faces several difficult hurdles such as cell production and purification, long-term survival, and functional integration after transplantation. Recently, in vivo reprogramming, which uses endogenous cells for tissue repair, has emerged as a new approach to circumvent cell transplantation. Up till now, in vivo reprogramming has been practiced in the mouse pancreas, heart, brain, and spinal cord with various degrees of success. In this review, we summarize the progress made, therapeutic potentials, and the challenges ahead in this emerging research area.

Authors and Affiliations

Saman Esmaeilnejad, Esmaeil Rahimi, Mohammad Sajad Emami-Aleagha, Iman Sadeghi

Keywords

Related Articles

Evaluation of the status of antibiotic prescription in patients admitted to a teaching hospital in west of Iran

BACKGROUND: The aim of this study was to evaluate the status of the appropriate use of antibiotics by type, dosage, and length of treatment and the route of administration in Tohid teaching hospital, Sanandaj, Iran. METH...

Correlation between Klotho changes and calcium-phosphate concentration in the serum at early stages of multiple sclerosis

BACKGROUND: There are several studies indicating that an anti-aging protein, namely Klotho protein, participates in the regulation of calcium and phosphate metabolism. In addition, we showed that Klotho protein was invol...

A case report of stomach and esophagus melanoma with liver metastases in a 63-year-old woman

BACKGROUND: Melanoma originates from melanocytes, which are dendritic pigmented cells. Malignant melanoma is divided into cutaneous and non-cutaneous types, and cutaneous one is the most common type. Gastric melanoma has...

A case of recurrent eccrine porocarcinoma

BACKGROUND: Eccrine porocarcinoma, first described in 1963, is a rare malignant lesion arising from the eccrine sweat glands. It is usually a primary tumor, even more commonly, a malignant degeneration of an eccrine poro...

A survey of factors related to urine iodine levels in elementary school children, Kurdistan, Iran

BACKGROUND: Iodine deficiency disorders (IDD) control program has two important factors: annual monitoring of urine iodine levels and controlling iodized salt consumed in the community. Preserving the iodine indexes in d...

Download PDF file
  • EP ID EP286136
  • DOI -
  • Views 121
  • Downloads 0

How To Cite

Saman Esmaeilnejad, Esmaeil Rahimi, Mohammad Sajad Emami-Aleagha, Iman Sadeghi (2017). In vivo reprogramming: A new approach for tissue repair in chronic diseases. Chronic Diseases Journal, 5(2), 80-89. https://europub.co.uk/articles/-A-286136